A nurse-engineer team at the University of Massachusetts Amherst has been honored with an ANA Innovation Award for inventing ...
Findings showed after 52 weeks, significant improvements in 2MWD and 6MWD were seen with Flebogamma 5% DIF 1mg/kg compared with placebo. Topline data were announced from a phase 2/3 trial ...
Intravenous: means “into the vein.” Efficacy data revealed that between three arms — Keytruda (pembrolizumab)/Welireg (62 patients; arm B4), Lenvima/Welireg (64 patients; arm B5) and Keytruda/Lenvima ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback